Nucleus Capital is a venture capital firm dedicated to supporting purpose-driven entrepreneurs tackling systemic challenges to planetary health. They invest at the Pre-Seed and Seed stages, focusing on sectors such as Programmable Biology, Food Technology, and Green Industrials. Their investment approach is thesis-driven, with a concentrated portfolio active in Europe and the US. They prefer to lead or co-lead rounds, providing not only capital but also strategic support tailored to the unique needs of scientific ventures.
Is Nucleus Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Nucleus Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€150,000 - €1,000,000
When approaching Nucleus Capital, founders should highlight the scientific rigor and scalability of their solution, demonstrating a clear pathway to impact within planetary health. Articulate how your technology or business model addresses a systemic challenge and why your team is uniquely positioned to execute. Be prepared to discuss both the technical depth and the broader market implications, as Nucleus values ventures that can drive systemic change and have a credible plan for early traction in Europe or the US.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.